Dr. Hussein Wafapoor, M.D.
What this data tells you about Dr. Wafapoor
Dr. Hussein Wafapoor is an ophthalmology in Fort Myers, FL, with 19 years in practice. Based on federal Medicare data, Dr. Wafapoor performed 108,266 Medicare services across 8,313 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wafapoor received a total of $5,077 from 8 pharmaceutical and/or device companies across 13 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wafapoor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 82,740 | $29 | $76 |
| Retinal imaging (OCT scan) | 5,281 | $29 | $85 |
| Eye injection for retinal disease | 3,949 | $100 | $270 |
| Injection, ranibizumab, 0.1 mg | 3,540 | $186 | $695 |
| Aflibercept eye injection (Eylea) | 3,302 | $695 | $1,890 |
| Retinal photography (fundus photo) | 2,955 | $28 | $103 |
| Comprehensive eye exam, established patient | 2,618 | $91 | $260 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,353 | $214 | $544 |
| Unclassified drugs | 978 | $1,455 | $6,861 |
| Comprehensive eye exam, new patient | 341 | $96 | $309 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 245 | $158 | $400 |
| Eye exam, established patient, focused | 232 | $68 | $182 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 196 | $105 | $214 |
| New patient office visit (45-59 min) | 152 | $118 | $348 |
| Extended exam of the back part of the eye with retinal drawing | 98 | $17 | $53 |
| 2d ultrasound scan of eye tissue and structures | 81 | $36 | $109 |
| Steroid injection (triamcinolone) | 46 | $1 | $3 |
| Destruction of growth of retina using a laser | 28 | $422 | $1,126 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 25 | $899 | $2,427 |
| Visual field test, extended | 24 | $47 | $130 |
| Destruction of leaking blood vessels of retina using laser | 18 | $274 | $719 |
| Repair of detached retina using a laser | 15 | $206 | $624 |
| Photocoagulation treatment to prevent detachment of retina | 13 | $182 | $1,111 |
| Injection of drug or substance into membrane covering eyeball | 13 | $40 | $135 |
| Removal of eye fluid (vitreous) between lens and retina | 12 | $657 | $1,895 |
| Repair of detached retina by injection of air or gas | 11 | $710 | $1,865 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Payments are distributed across multiple categories with no single dominant type.
Geographic Context
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wafapoor is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and mixed engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wafapoor experienced with eye injection (vabysmo/faricimab)?
Does Dr. Wafapoor receive payments from pharmaceutical companies?
How do Dr. Wafapoor's costs compare to other ophthalmologys in Fort Myers?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology